Le Lézard
Classified in: Health
Subjects: CCA, FVT

Varian to Attend Upcoming Investor Events


PALO ALTO, Calif., Nov. 25, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that J. Michael Bruff, chief financial officer* and Anshul Maheshwari, vice president, Treasury and Investor Relations* will be participating in the following investor conferences:

Evercore ISI 2nd Annual HealthCONx Conference in Boston, MA
Wednesday, December 4, 2019 at 8:00 a.m. Eastern Time

Piper Jaffray 31st Annual Healthcare Conference in New York, NY
Thursday, December 5, 2019 at 8:00 a.m. Eastern Time

Information about the webcast of the company's presentation will be available through a link on the company website at www.varian.com/investors.

*Effective December 1, 2019

About Varian
At Varian, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 9,200 employees across 70 locations keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Investor Relations Contact

Anshul Maheshwari
Vice President, Treasury and Investor Relations
+1 (650) 424-6081
[email protected]

Press Contact

Mark Plungy
Director, Public Relations
+1 (650) 424-5630
[email protected]

SOURCE Varian


These press releases may also interest you

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...

at 18:15
Equality Health Foundation, the philanthropic partner of Equality Health LLC and an organization dedicated to advancing health equity and improving well-being access for underserved communities, proudly announces its expansion into Virginia and...

at 18:01
Aflac Incorporated announced today that it has revised the time of its first quarter webcast teleconference call on Thursday, May 2, 2024 to 7:00 a.m. (ET), which is one hour earlier than the originally scheduled 8:00 a.m. start time, to avoid...



News published on and distributed by: